WuXi Companies' Shares Rise on Receding Worries About Potential U.S. Sanctions
By Sherry Qin
Shares of the WuXi family of biotech and research companies listed both in Shanghai and Hong Kong rose sharply on receding worries about potential U.S. sanctions.
WuXi AppTec's Shanghai-listed shares rose 7.3% to 59.10 yuan (US$8.21) and gained 11% to 55.85 Hong Kong dollars(US$7.13) in Hong Kong Monday.
Sister company Wuxi Biologics also jumped 11% to HK$20.95, while WuXi XDC Cayman, Wuxi Biologics' contract medical research unit, soared 18%.
Despite the gains, WuXi AppTec and Wuxi Biologics are still down 30% and 29%, respectively, since the start of the year.
U.S. President Joe Biden issued an executive order Wednesday to "prevent large-scale transfer of Americans' personal data to countries of concern," including genomic, biometric, geolocation and financial data. The countries of concern are China, Russia, North Korea, Iran, Cuba and Venezuela, and have a record of misusing data on Americans, an official said.
In late January, the U.S. lawmakers introduced a bill that aims to bar federal contracts with Beijing Genomics Institute and some Chinese biotech entities due to alleged connections with the People's Liberation Army. The WuXi companies were among those named in the bill.
Analysts reckon the executive order signals it would restrict activities of genomics companies in the U.S. rather than contract research organizations, like the WuXi companies.
"The scope of the restriction is narrowed [to genomic sequencing], also not single out a specific company," said Jialin Zhang, Nomura's head of China healthcare research.
Write to Sherry Qin at sherry.qin@wsj.com
(END) Dow Jones Newswires
March 04, 2024 01:26 ET (06:26 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Q4 Stock Market Outlook: Where We See Opportunities for Investors
-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
This Cheap Stock Is Still a Buy Even After 50% Rally
-
10 Top-Performing Dividend Stocks of Q3 2024
-
33 Undervalued Stocks
-
Communication Services: Cable’s Broadband Dominance Isn’t as Strong as It Once Was
-
Technology: Strength Continues, With Software Presenting the Best Buying Opportunities
-
Best- and Worst-Performing Stocks of Q3 2024
-
Top Stocks to Own From the Best Fund Managers
-
2 Cheap Stocks Top Managers Have Been Buying